Download PDF
Planta Med 2012; 78(10): 962-967
DOI: 10.1055/s-0031-1298579
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

High Molecular Weight Constituents of Cranberry Interfere with Influenza Virus Neuraminidase Activity In Vitro

Esther Oiknine-Djian   *
1   Department of Biochemistry and Molecular Biology, Chanock Center of Virology, IMRIC, Hadassah-Hebrew University Medical and Dental Schools, Jerusalem, Israel
,
Yael Houri-Haddad   *
2   Department of Prosthodontics, Hadassah-Hebrew University Medical and Dental Schools, Jerusalem, Israel
,
Ervin Itshak Weiss
2   Department of Prosthodontics, Hadassah-Hebrew University Medical and Dental Schools, Jerusalem, Israel
,
Itzhak Ofek
3   Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
,
Evguenia Greenbaum
1   Department of Biochemistry and Molecular Biology, Chanock Center of Virology, IMRIC, Hadassah-Hebrew University Medical and Dental Schools, Jerusalem, Israel
,
Kevan Hartshorn
4   Department of Medicine, Boston University School of Medicine, Boston, MA, USA
,
Zichria Zakay-Rones
1   Department of Biochemistry and Molecular Biology, Chanock Center of Virology, IMRIC, Hadassah-Hebrew University Medical and Dental Schools, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

received 27 December 2011
revised 24 April 2012

accepted 25 April 2012

Publication Date:
15 May 2012 (online)

    Permissions and Reprints

Abstract

Cranberry juice contains high molecular weight non-dialyzable material (NDM) which was found to inhibit hemagglutination induced by the influenza virus (IV) as well as to neutralize the cytotoxicity of IV in cell cultures. Because influenza virus surface glycoproteins hemagglutinin (HA) and neuraminidase (NA) are involved in viral replication and in the infectious process, we sought in the present study to examine the effect of NDM on neuraminidases which are the target of most anti-influenza drugs today. NDM inhibited the NA enzymatic activity of influenza A and B strains as well as that of Streptococcus pneumoniae. This finding is of importance considering the emergence of influenza isolates resistant to antiviral drugs, reaching 90 % in some places. The anti-NA activity of NDM, evaluated by the MUNANA method and expressed as the concentration required for 50 % inhibition (IC50), was most potent against N1 (IC50, 192 µg/mL), less active against BN and N2 (IC50, 509 µg/mL and 1128 µg/mL, respectively), and moderately active against Streptococcus pneumoniae NA (IC50, 594 µg/mL). The in vitro findings of the present study suggest that cranberry constituents may have a therapeutic potential against both A and B influenza virus infections and might also interfere with the development of secondary bacterial complications.

Key words

cranberry juice - NDM - Vaccinium macrocarpon Ait - Ericaceae - neuraminidase - influenza virus

* These authors contributed equally to the study.


 

  • References

  • 1 Zakay-Rones Z. Human influenza vaccines and assessment of immunogenicity. Expert Rev Vaccines 2010; 9: 1423-1439
    CrossrefPubMedGoogle Scholar
  • 2 Monto AS. The role of antivirals in the control of influenza. Vaccine 2003; 21: 1796-1800
    CrossrefPubMedGoogle Scholar
  • 3 Suzuki H, Saito R, Masuda H, Oshitani H, Sato M, Sato I. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother 2003; 9: 195-200
    CrossrefPubMedGoogle Scholar
  • 4 Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y. Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005; 437: 1108
    CrossrefPubMedGoogle Scholar
  • 5 Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van ʼt Veen A, van der Vries E, te Wierik M, Koopmans M. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010. Antiviral Res 2011; 92: 81-89
    CrossrefPubMedGoogle Scholar
  • 6 Mochalova L, Bright R, Xu X, Korchagina E, Chinarev A, Bovin N, Klimov A. Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconj J 2010; 27: 321-327
    CrossrefPubMedGoogle Scholar
  • 7 Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 2000; 74: 6015-6020
    CrossrefPubMedGoogle Scholar
  • 8 Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 2004; 78: 12665-12667
    CrossrefPubMedGoogle Scholar
  • 9 Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25: 2842-2851
    CrossrefPubMedGoogle Scholar
  • 10 Shmuely H, Ofek I, Weiss EI, Rones Z, Houri-Haddad Y. Cranberry components for the therapy of infectious disease. Curr Opin Biotechnol 2012; 23: 148-152
    CrossrefPubMedGoogle Scholar
  • 11 Weiss EI, Houri-Haddad Y, Greenbaum E, Hochman N, Ofek I, Zakay-Rones Z. Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res 2005; 66: 9-12
    CrossrefPubMedGoogle Scholar
  • 12 Lipson SM, Sethi L, Cohen P, Gordon RE, Tan IP, Burdowski A, Stotzky G. Antiviral effects on bacteriophages and rotavirus by cranberry juice. Phytomedicine 2007; 14: 23-30
    PubMedGoogle Scholar
  • 13 De Bruyne T, Pieters L, Witvrouw M, De Clercq E, Vanden Berghe D, Vlietinck AJ. Biological evaluation of proanthocyanidin dimers and related polyphenols. J Nat Prod 1999; 62: 954-958
    CrossrefPubMedGoogle Scholar
  • 14 Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res 2004; 32: 132-140
    CrossrefPubMedGoogle Scholar
  • 15 Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa . Planta Med 2008; 74: 847-851
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Bodet C, Grenier D, Chandad F, Ofek I, Steinberg D, Weiss EI. Potential oral health benefits of cranberry. Crit Rev Food Sci Nutr 2008; 48: 672-680
    CrossrefPubMedGoogle Scholar
  • 17 Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med 1991; 324: 1599
    PubMedGoogle Scholar
  • 18 Labrecque J, Bodet C, Chandad F, Grenier D. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis . J Antimicrob Chemother 2006; 58: 439-443
    CrossrefPubMedGoogle Scholar
  • 19 Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res 2006; 85: 235-239
    CrossrefPubMedGoogle Scholar
  • 20 Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, Mador N, Greenbaum E, Wolf DG. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol 2009; 44: 138-140
    CrossrefPubMedGoogle Scholar
  • 21 Hartley CA, Reading PC, Ward AC, Anders EM. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol 1997; 142: 75-88
    CrossrefPubMedGoogle Scholar
  • 22 Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D–N-acetylneuraminate) substrate. Anal Biochem 1979; 94: 287-296
    CrossrefPubMedGoogle Scholar
  • 23 Tecle T, White MR, Crouch EC, Hartshorn KL. Inhibition of influenza viral neuraminidase activity by collectins. Arch Virol 2007; 152: 1731-1742
    CrossrefPubMedGoogle Scholar
  • 24 Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999; 26: 189-195
    CrossrefPubMedGoogle Scholar
  • 25 Hartshorn KL, Liou LS, White MR, Kazhdan MM, Tauber JL, Tauber AI. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol 1995; 154: 3952-3960
    PubMedGoogle Scholar
  • 26 McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae . J Infect Dis 2003; 187: 1000-1009
    CrossrefPubMedGoogle Scholar
  • 27 McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186: 341-350
    CrossrefPubMedGoogle Scholar
  • 28 Tashiro M, Beppu Y, Sakai K, Kido H. Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs. Arch Virol 1996; 141: 1571-1577
    CrossrefPubMedGoogle Scholar
  • 29 Dalia AB, Standish AJ, Weiser JN. Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils. Infect Immun 2010; 78: 2108-2116
    CrossrefPubMedGoogle Scholar
  • 30 Gubareva LV, Webster RG, Hayden FG. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res 2002; 53: 47-61
    CrossrefPubMedGoogle Scholar
  • 31 Chen Z, Aspelund A, Jin H. Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine 2008; 26: 361-371
    CrossrefPubMedGoogle Scholar
  • 32 Saito T, Nakaya Y, Suzuki T, Ito R, Saito H, Takao S, Sahara K, Odagiri T, Murata T, Usui T, Suzuki Y, Tashiro M. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol 2004; 74: 336-343
    CrossrefPubMedGoogle Scholar
  • 33 Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 2010; 285: 28403-28409
    CrossrefPubMedGoogle Scholar
  • 34 Malaisree M, Rungrotmongkol T, Decha P, Intharathep P, Aruksakunwong O, Hannongbua S. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1. Proteins 2008; 71: 1908-1918
    CrossrefPubMedGoogle Scholar
  • 35 von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 2007; 6: 967-974
    CrossrefPubMedGoogle Scholar